 | 美国健康财务（Ameriprise Financial, Inc.） 明尼阿波利斯市 纽交所: AMP 2024年10月23日 | ||||
阿莫斯莱斯金融报告
2024年第三季度业绩
| 每股摊薄收益 | 除AOCI之外的股东权益回报 (1) | |||||||||||||
Q3 2024 | Q3 2024 | |||||||||||||
| 通用会计原则(GAAP) | $5.00 | 通用会计原则(GAAP) | 40.1% | |||||||||||
调整营业收入 | $8.10 | 调整后营运 | 49.6% | |||||||||||
| 调整后营运，不包括解锁和裁员费用 | $9.02 | 调整后营运，不包括解锁 | 50.7% | |||||||||||
•第三季度调整后的每股稀释收益增加了17%，为9.02美元，不包括解锁和与公司加强运营效率和效益倡议相关的赔偿费用。
•第三季度按照通用会计准则计算的每股稀释净利润为
5.00美元，相比一年前的8.14美元，主要受到衍生品估值和市场风险利益的影响。
5.00美元，相比一年前的8.14美元，主要受到衍生品估值和市场风险利益的影响。
•资产管理和管理规模达到1.5万亿美元，较客户净流入和市场增值增长22%。
资产管理和管理规模达到1.5万亿美元，较客户净流入和市场增值增长22%。
资产管理和管理规模达到1.5万亿美元，较客户净流入和市场增值增长22%。
资产管理和管理规模达到1.5万亿美元，较客户净流入和市场增值增长22%。
资产管理和管理规模达到1.5万亿美元，较客户净流入和市场增值增长22%。
•调整后的营业净收入增长11%，来自有机增长、强劲的股票市场和更高的息差收入。
•总部和行政开支继续得到有效管理，显示公司对运营效率和效益的专注。
•税前调整后的营业利润率为27%(2) 调整后的净资产收益率为51%(3).
•公司在本季度向股东返还了71300万资本，展示其资产负债表实力和强劲的自由现金流生成能力。
| 来自吉姆·克拉奇奥洛，董事长兼首席执行官的观点 | ||
美林金融再次交出了一个非常出色的季度业绩，进一步展示了我们客户和顾问价值主张、互补业务以及战略聚焦的实力。 我们在业务各领域实现了强劲的营业收入和利润增长。在积极的市场环境和我们的规划专业知识的支持下，客户进行更广泛的投资。 资金流入基于费用的投资咨询账户显著增加，交易活动持续强劲，顾问生产力再次达到新高。 在公司各方面，我们继续推动营运效率，同时为增长进行投资。我们的财务实力和自由现金流生成仍然是关键的区别因素，并在市场周期中获得灵活性，持续实现强劲的业绩并向股东返还资本。 | ||
(1) 不包括AOCI的净资产收益率是根据过去12个月的数据计算的。
(2) 不包括解锁和离职。
(3) 不包括解锁。解锁影响反映了公司对保险和年金估值假设以及模型变化进行的年度审查。
1
| 美国健康财务（Ameriprise Financial, Inc.） | |||||||||||||||||||||||||||||||||||
第三财季摘要 | |||||||||||||||||||||||||||||||||||
季度结束 2022年9月30日 | % Better/ (更糟) | 截至年底 2022年9月30日 | % 更好/ (更糟) | ||||||||||||||||||||||||||||||||
| (以百万计，除每股金额外，未经审计) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||||||||||
| 按照通用会计准则计算的净收益 | $ | 511 | $ | 872 | (41)% | $ | 2,330 | $ | 2,179 | 7% | |||||||||||||||||||||||||
| 调整后的营业收益 | $ | 828 | $ | 745 | 11% | $ | 2,588 | $ | 2,350 | 10% | |||||||||||||||||||||||||
调整后的营运收入，不包括解锁（请参阅第24页和25页的调整） | $ | 902 | $ | 823 | 10% | $ | 2,662 | $ | 2,428 | 10% | |||||||||||||||||||||||||
调整后的营运收入，不包括解锁和离职费用（请参阅第24页和25页的调整） | $ | 921 | $ | 829 | 11% | $ | 2,705 | $ | 2,434 | 11% | |||||||||||||||||||||||||
| GAAP 稀释后每股净收益 | $ | 5.00 | $ | 8.14 | (39)% | $ | 22.53 | $ | 20.08 | 12% | |||||||||||||||||||||||||
| 每股调整后的营运收益 | $ | 8.10 | $ | 6.96 | 16% | $ | 25.03 | $ | 21.66 | 16% | |||||||||||||||||||||||||
每股调整后的营运收益，不包括解锁（请参阅第24页和25页的调解） | $ | 8.83 | $ | 7.68 | 15% | $ | 25.74 | $ | 22.38 | 15% | |||||||||||||||||||||||||
每股调整后的营运收益，不包括解锁和裁员费用（请参阅第24页和25页的调解） | $ | 9.02 | $ | 7.74 | 17% | $ | 26.15 | $ | 22.43 | 17% | |||||||||||||||||||||||||
| GAAP净资产回报，不含AOCI | 40.1 | % | 44.4 | % | 40.1 | % | 44.4 | % | |||||||||||||||||||||||||||
| 调整后的净资产回报，不含AOCI | 49.6 | % | 48.4 | % | 49.6 | % | 48.4 | % | |||||||||||||||||||||||||||
调整后的净资产回报，不含AOCI和解锁（请参阅第24页和25页的调解） 29) | 50.7 | % | 49.6 | % | 50.7 | % | 49.6 | % | |||||||||||||||||||||||||||
| GAAP净资产，不含AOCI | $ | 6,816 | $ | 6,665 | 2% | $ | 6,816 | $ | 6,665 | 2% | |||||||||||||||||||||||||
可用于资本充足的资本 (请参见第p。 27) | $ | 5,523 | $ | 5,247 | 5% | $ | 5,523 | $ | 5,247 | 5% | |||||||||||||||||||||||||
| 加权平均流通股数: | |||||||||||||||||||||||||||||||||||
| Basic | 100.4 | 104.9 | 101.6 | 106.4 | |||||||||||||||||||||||||||||||
| Diluted | 102.2 | 107.1 | 103.4 | 108.5 | |||||||||||||||||||||||||||||||
2024年第三季度GAAP结果包括对衍生品估值和市场风险受益的不利市场影响，而去年同期包括对衍生品估值和市场风险受益的有利市场影响。
公司在本季度完成了年度精算假设更新，导致每股税后不利影响为7400万美元，或每股0.73美元。这主要与变量年金的更新续存假设有关。
此外，调整后的税后营运结果包括2024年第三季度1900万美元的离职费用，以及年初至今4300万美元的离职费用。离职与公司旨在增强运营效率和效果、进一步加强客户体验和未来盈利能力的举措有关。
2
| 美国健康财务（Ameriprise Financial, Inc.） | |||||||||||||||||
| 咨询与财富管理业务部门调整后营业利润率 | |||||||||||||||||
| 截至9月30日的季度 | % 更好/ (更糟) | ||||||||||||||||
| (以百万计，未经审计) | 2024 | 2023 | |||||||||||||||
| 调整后的营业净收入 | $ | 2,742 | $ | 2,407 | 14% | ||||||||||||
| 营销费用 | 1,488 | 1,253 | (19)% | ||||||||||||||
| 利息和负债费用 | 9 | 6 | (50)% | ||||||||||||||
| 一般及管理费用 | 419 | 419 | —% | ||||||||||||||
调整后的营业费用 | 1,916 | 1,678 | (14)% | ||||||||||||||
税前调整后营业利润 | $ | 826 | $ | 729 | 13% | ||||||||||||
| 税前调整后的营业利润率 | 30.1 | % | 30.3 | % | (20) 基点 | ||||||||||||
| 截至9月30日的季度 | % 更好/ (更糟) | |||||||||||||
| (以十亿计，除非另有说明) | 2024 | 2023 | ||||||||||||
| 客户资产总额 | $ | 1,024 | $ | 816 | 26% | |||||||||
客户净流入总额 | $ | 8.6 | $ | 8.9 | (3)% | |||||||||
Wrap净流入 | $ | 8.0 | $ | 5.4 | 48% | |||||||||
AWM现金余额 | $ | 40.1 | $ | 40.5 | (1)% | |||||||||
| 每位顾问的调整后营业净收入（万美元，TTM） | $ | 997 | $ | 901 | 11% | |||||||||
咨询与财富管理 持续展现盈利的有机增长，创下历史新高 银行的税前调整运营收入达到82600万美元，利润率超过30%，受核心业务增长驱动，以及更高的稳健净投资收入。
银行调整后的营业净收入增长了14%，达到27亿美元，主要由于客户资产增长、交易活动增加以及净投资收入增长了6%。
调整后的营业费用较去年增长了14%，达到19亿美元。总务及行政费用与去年持平，为41900万美元。去年扣除2000万美元的监管准备金后，总务及行政费用增长了5%，主要来自成交量相关的业务增长费用。
客户和顾问始终保持关注，专注于调整投资组合，以满足各种市场周期下的财务规划目标。
•客户总资产增长26%，达到1万亿美元的历史新高，Wrap资产增长28%，达到5690亿美元。
•期货流量增长至80亿美元，年化增长率为6%，这是客户偏好转向咨询产品的早期迹象。
•交易活动增长19%，各产品领域均呈现强劲增长。
•客户现金总额为$830亿，比一年前增加$105亿。在本季度，第三方货币市场基金的增长部分抵消了经纪人发行的CD和存款证书等期限产品的下降。
•客户现金清理余额稳定在约$280亿左右。
•银行资产增长了7%，达到232亿美元，在这种预计利率较低的环境下提供可持续的净投资收入。
•在过去12个月的基础上，每位顾问的调整后营业净收入达到99.7万美元，比增强的生产力、业务增长和市场增值提高了11%。
•顾问人数增加到10,368人，这反映了本季度增加了71位经验丰富的顾问，以及持续稳固的顾问留存率。
3
| 美国健康财务（Ameriprise Financial, Inc.） | |||||||||||||||||
| 资产管理部门调整后的营运业绩 | |||||||||||||||||
| 截至9月30日的季度 | % 更好/ (更糟) | ||||||||||||||||
| (以百万计，未经审计) | 2024 | 2023 | |||||||||||||||
| 调整后的营业净收入 | $ | 882 | $ | 826 | 7% | ||||||||||||
| 营销费用 | 250 | 234 | (7)% | ||||||||||||||
| 推迟收购成本摊销 | 2 | 1 | 未出现数据 | ||||||||||||||
| 利息和负债费用 | 2 | 2 | —% | ||||||||||||||
| 一般及管理费用 | 383 | 390 | 2% | ||||||||||||||
| 调整后的营业费用 | 637 | 627 | (2)% | ||||||||||||||
| 税前调整后营业利润 | $ | 245 | $ | 199 | 23% | ||||||||||||
Net pretax adjusted operating margin (1) | 40.9 | % | 35.7 | % | |||||||||||||
| 截至9月30日的季度 | % 更好/ (更糟) | ||||||||||||||||
| （以亿为单位） | 2024 | 2023 | |||||||||||||||
| 总分部资产管理 | $ | 672 | $ | 587 | 14% | ||||||||||||
| 净流入 | |||||||||||||||||
全球零售净资产流动，不包括传统保险合作伙伴 | $ | (2.7) | $ | (3.8) | 29% | ||||||||||||
模型交付资产净流入 (2) | 1.2 | 0.2 | 未出现数据 | ||||||||||||||
零售净资产净流入总额和模型交付资产净流入 (2) | (1.5) | (3.6) | 58% | ||||||||||||||
全球机构净资产流入，不包括传统保险合作伙伴 | — | 0.5 | 未出现数据 | ||||||||||||||
传统保险合作伙伴资产净流入 | (0.9) | (0.9) | —% | ||||||||||||||
总净资产和资产总额流入 (2) | $ | (2.4) | $ | (4.0) | 40% | ||||||||||||
(1) 请参阅页面上的调解 13. | |||||||||||||||||
(2) 模型交付资产顾问资金流入估计根据资产的周期性变化减去根据策略回报计算的表现基础上的一季度滞后。 | |||||||||||||||||
| Nm 不明确 - 方差等于或大于100% | |||||||||||||||||
资产管理 调整后的营业净收入增长了7%，达到88200万美元，税前调整营业收益增长了23%，达到24500万美元。财务业绩反映了股市走高的影响和费用管理措施的积极影响，这大大抵消了净流出的累积影响。净税前调整营业利润率达到41%，超过了公司的目标区间。
调整后的营业费用增加了2％。总务和管理费用较去年同比提高了2％，反映出公司不断改进运营效率和效益的初期收益，以进一步加强客户体验和未来的盈利能力。
管理资产总额增长14%，至6720亿美元。基础费率保持稳定。
总净流出改善了40%，达到24亿美元，其中包括涉及传统保险合作伙伴的9亿美元流出。零售和模型投递净流出为15亿美元，比去年同期21亿美元的改善来自北美和欧洲、中东、非洲两地销售增长和强劲的模型投递净流入。
4
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||
| 养老保障解决方案部门调整后营业费用结果 | ||||||||||||||
| 截至9月30日的季度 | % 更好/ (更糟) | |||||||||||||
| (以百万计，未经审计) | 2024 | 2023 | ||||||||||||
| 调整后的营业净收入 | $ | 973 | $ | 876 | 11% | |||||||||
| 调整后的营业费用 | 855 | 776 | (10)% | |||||||||||
| 税前调整后营业利润（包括解锁） | $ | 118 | $ | 100 | 18% | |||||||||
| 解锁 | (90) | (104) | 13% | |||||||||||
| 税前调整后营业利润不包括解锁 | $ | 208 | $ | 204 | 2% | |||||||||
养老与保障解决方案 税前调整后的营运收入，不包括解锁，按年计增长了2%，达到20800万美元，截至目前年度为60300万美元。业务的强劲和稳定表现反映了利息收入增加和股票市场上涨带来的好处，部分抵消了与持续强劲销售水平相关的较高分销费用。这些高质量的业务继续产生强劲的自由现金流和资本回报，具有不同风险配置文件。
养老与保障解决方案销售额增长15％至14亿美元，主要受到理财与财富管理客户对结构型可变年金和可变通用寿险产品的需求推动。
5
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||
| 公司及其他分部调整后的营运结果 | ||||||||||||||
| 截至9月30日的季度 | % 更好/ (更糟) | |||||||||||||
| (以百万计，未经审计) | 2024 | 2023 | ||||||||||||
| 企业及其他 | $ | (145) | $ | (74) | (96)% | |||||||||
已结案区块 (1) | 2 | 2 | —% | |||||||||||
| 税前调整后营业利润 | $ | (143) | $ | (72) | (99)% | |||||||||
解锁 | (4) | 5 | 未出现数据 | |||||||||||
解锁以外的税前调整运营收益 | $ | (139) | $ | (77) | (81)% | |||||||||
除解锁外的长期护理 | $ | 13 | $ | 5 | 未出现数据 | |||||||||
| 除解锁外的固定年金 | (7) | (8) | 13% | |||||||||||
| 解锁以外的税前调整运营收益 | $ | 6 | $ | (3) | 未出现数据 | |||||||||
(1) 长期护理和固定年金。 | ||||||||||||||
| 不适用-方差等于或大于100% | ||||||||||||||
公司及其他，不包括关闭的部分， 税前调整后的营运亏损为14500万美元，其中5600万美元与3400万美元的离职和离职计划费用有关，以及2200万美元的费用用于加速公司向基于云技术平台的过渡，与强劲表现相关的更高薪酬预备金以及股权激励计划的按市值核算影响。
开多期护理 除解锁外的税前调整营运收入为1300万美元，或者截至目前为止的4100万美元，延续了改善表现趋势。
固定年金 税前调整后的营运亏损，不包括解锁，符合预期，为700万美元。
税收
第三季度，营运有效税率降至20.8％，年初至今税率为20.1％。预计全年有效税率将在20％至21％的区间内。
联系方式
投资者关系: 媒体关系:
Alicia A. Charity Paul W. Johnson
阿莫斯莱斯金融 阿莫斯莱斯金融
(612) 671-2080 (612) 671-0625
alicia.a.charity@ampf.com paul.w.johnson@ampf.com
斯蒂芬妮·M·拉贝
阿莫斯莱斯金融
(612) 671-4085
stephanie.m.rabe@ampf.com
6
阿莫斯莱斯金融
在阿莫斯莱斯金融，我们一直致力于帮助人们对自己的财务未来感到自信长达130年。凭借广泛的投资建议、全球货币管理能力和保险解决方案，以及超过10,000名金融顾问的全国网络，我们拥有实力和专业知识来满足个人和机构投资者的所有金融需求。
阿莫斯莱斯金融服务有限责任公司提供财务规划服务、投资、保险和年金产品。哥伦比亚所有基金类型由哥伦比亚管理投资分销商公司分销，是FINRA成员，由哥伦比亚管理投资顾问有限责任公司管理。Threadneedle 国际有限公司、哥伦比亚Threadneedle 资产管理有限公司、哥伦比亚Threadneedle (EM) 投资有限公司和Pyrford 国际有限公司是哥伦比亚管理投资顾问有限责任公司在英国注册的投资顾问联属公司。RiverSource 保险和年金产品由RiverSource 人寿保险公司发行，在纽约仅由New York的RiverSource 人寿保险公司发行，总部位于纽约的Albany。只有New York的RiverSource 人寿保险公司被授权在纽约州销售保险和年金产品。这些公司是阿莫斯莱斯金融公司的组成部分。CA许可证号码＃0684538。RiverSource Distributors, Inc.（分销商）是FINRA成员。
Non-GAAP Financial Measures
The company believes the presentation of adjusted operating measures, available capital for capital adequacy and other non-GAAP financial measures, and the corresponding ratios, best represents the underlying performance of our core operations and facilitates a more meaningful trend analysis without the distortion of various adjustment items. Management uses non-GAAP financial measures to evaluate our financial performance on a basis comparable to that used by some securities analysts and investors and to provide a valuable perspective for investors. These non-GAAP financial measures are taken into consideration, to varying degrees, for purposes of business planning and analysis and for certain compensation-related matters. Non-GAAP financial measures are intended to supplement investors’ understanding of our performance and should not be considered alternatives for financial measures presented in accordance with GAAP. These measures are discussed in more detail below and may not be comparable to other companies’ similarly titled non-GAAP financial measures. Non-GAAP financial measure reconciliations can be found on the subsequent pages.
Forward-Looking Statements
This news release contains forward-looking statements that reflect management’s plans, estimates and beliefs. Actual results could differ materially from those described in these forward-looking statements. Examples of such forward-looking statements include:
•statements of the company’s plans, intentions, positioning, expectations, objectives or goals, including those relating to asset flows, mass affluent and affluent client acquisition strategy, client retention and growth of our client base, financial advisor productivity, retention, recruiting and enrollments, the introduction, cessation, terms or pricing of new or existing products and services, general and administrative costs, net pretax adjusted operating margin, consolidated tax rate, return of capital to shareholders, and excess capital position and financial flexibility to capture additional growth opportunities;
•other statements about future economic performance, the performance of equity markets and interest rate variations and the economic performance of the United States and of global markets;
•statements estimating the financial impacts and future profitability arising from the company’s initiatives to enhance operational efficiency and effectiveness;
7
•statements about higher sustainable net investment income at the bank and the forecast for a lower rate environment;
•statements about continued improved performance of long term care operating earnings;
•statements estimating the expected full year 2024 operating effective tax rate; and
•statements of assumptions underlying such statements.
The words “believe,” “expect,” “anticipate,” “optimistic,” “intend,” “plan,” “aim,” “will,” “may,” “should,” “could,” “would,” “likely,” “forecast,” “on track,” “project,” ”continue,” “able to remain”, “resume,” “deliver,” “develop,” “evolve,” “drive,” ”enable,” “flexibility,” “commitment,” “scenario,” “case,” “appear,” “expands” and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from such statements.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. Management cautions readers to carefully consider the risks described in the “Risk Factors” discussion under Part 1, Item 1A of and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2023 available at ir.ameriprise.com. Management undertakes no obligation to update publicly or revise any forward-looking statements.
The financial results discussed in this news release represent past performance only, which may not be used to predict or project future results. The financial results and values presented in this news release are based upon asset valuations that represent estimates as of the date of this news release and may be revised in the company’s Form 10-Q for the period ended September 30, 2024.
Ameriprise Financial announces financial and other information to investors through the company’s investor relations website at ir.ameriprise.com, as well as SEC filings, press releases, public conference calls and webcasts. Investors and others interested in the company are encouraged to visit the investor relations website from time to time, as information is updated and new information is posted. The website also allows users to sign up for automatic notifications in the event new materials are posted. The information found on the website is not incorporated by reference into this release or in any other report or document the company furnishes or files with the SEC.
8
| Ameriprise Financial, Inc. | ||||||||||||||||||||
| Consolidated GAAP Results | ||||||||||||||||||||
| (in millions, except per share amounts, unaudited) | 3 Qtr 2024 | 3 Qtr 2023 | % Better/ (Worse) | 2 Qtr 2024 | % Better/ (Worse) | |||||||||||||||
| Revenues | ||||||||||||||||||||
| Management and financial advice fees | $ | 2,573 | $ | 2,287 | 13% | $ | 2,456 | 5% | ||||||||||||
| Distribution fees | 513 | 463 | 11% | 505 | 2% | |||||||||||||||
| Net investment income | 934 | 809 | 15% | 921 | 1% | |||||||||||||||
| Premiums, policy and contract charges | 409 | 390 | 5% | 381 | 7% | |||||||||||||||
| Other revenues | 131 | 127 | 3% | 129 | 2% | |||||||||||||||
| Total revenues | 4,560 | 4,076 | 12% | 4,392 | 4% | |||||||||||||||
| Banking and deposit interest expense | 163 | 151 | (8)% | 172 | 5% | |||||||||||||||
| Total net revenues | 4,397 | 3,925 | 12% | 4,220 | 4% | |||||||||||||||
| Expenses | ||||||||||||||||||||
| Distribution expenses | 1,539 | 1,297 | (19)% | 1,450 | (6)% | |||||||||||||||
| Interest credited to fixed accounts | 118 | 139 | 15% | 185 | 36% | |||||||||||||||
| Benefits, claims, losses and settlement expenses | 430 | 120 | NM | 331 | (30)% | |||||||||||||||
| Remeasurement (gains) losses of future policy benefit reserves | (22) | (12) | 83% | (8) | NM | |||||||||||||||
| Change in fair value of market risk benefits | 566 | 168 | NM | 110 | NM | |||||||||||||||
| Amortization of deferred acquisition costs | 59 | 62 | 5% | 61 | 3% | |||||||||||||||
| Interest and debt expense | 87 | 84 | (4)% | 83 | (5)% | |||||||||||||||
| General and administrative expense | 975 | 950 | (3)% | 957 | (2)% | |||||||||||||||
| Total expenses | 3,752 | 2,808 | (34)% | 3,169 | (18)% | |||||||||||||||
| Pretax income | 645 | 1,117 | (42)% | 1,051 | (39)% | |||||||||||||||
| Income tax provision | 134 | 245 | (45)% | 222 | (40)% | |||||||||||||||
| Net income | $ | 511 | $ | 872 | (41)% | $ | 829 | (38)% | ||||||||||||
| Earnings per share | ||||||||||||||||||||
| Basic earnings per share | $ | 5.09 | $ | 8.31 | $ | 8.16 | ||||||||||||||
| Earnings per diluted share | $ | 5.00 | $ | 8.14 | $ | 8.02 | ||||||||||||||
| Weighted average common shares outstanding | ||||||||||||||||||||
| Basic | 100.4 | 104.9 | 101.6 | |||||||||||||||||
| Diluted | 102.2 | 107.1 | 103.4 | |||||||||||||||||
| NM Not Meaningful - variance equal to or greater than 100% | ||||||||||||||||||||
9
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||||||||
| 综述和资本概要 | ||||||||||||||||||||
| (单位：百万美元，除非另有说明，未经审计) | 2024年第3季 | 2023年第3季 | % 更好/ (更糟) | 2024年第2季 | % 更好/ (更糟) | |||||||||||||||
| 资产管理和行政资产 | ||||||||||||||||||||
| 投资和财富管理资产 | $ | 565,152 | $ | 440,703 | 28% | $ | 531,268 | 6% | ||||||||||||
| 资产管理资产 | 672,110 | 587,171 | 14% | 641,880 | 5% | |||||||||||||||
| 公司资产 | 523 | 349 | 50% | 490 | 7% | |||||||||||||||
| 剔除项 | (45,839) | (37,795) | (21)% | (44,136) | (4)% | |||||||||||||||
| 资产总管理 | 1,191,946 | 990,428 | 20% | 1,129,502 | 6% | |||||||||||||||
| 管理的总资产 | 314,173 | 242,336 | 30% | 298,468 | 5% | |||||||||||||||
| 总管理资产和总资产 | $ | 1,506,119 | $ | 1,232,764 | 22% | $ | 1,427,970 | 5% | ||||||||||||
| S&P 500 | ||||||||||||||||||||
| 每日平均 | 5,546 | 4,456 | 24% | 5,253 | 6% | |||||||||||||||
| 期末 | 5,762 | 4,288 | 34% | 5,460 | 6% | |||||||||||||||
加权股指期货（WEI） (1) | ||||||||||||||||||||
| 每日平均 | 3,528 | 2,903 | 22% | 3,358 | 5% | |||||||||||||||
| 期末 | 3,664 | 2,788 | 31% | 3,456 | 6% | |||||||||||||||
| 普通股 | ||||||||||||||||||||
| 期初余额 | 98.4 | 102.8 | (4)% | 99.6 | (1)% | |||||||||||||||
| 回购 | (1.3) | (1.5) | 13% | (1.3) | —% | |||||||||||||||
| 股份发行 | 0.2 | 0.3 | (33)% | 0.1 | 未出现数据 | |||||||||||||||
| 其他 | (0.1) | (0.2) | 50% | — | —% | |||||||||||||||
| 总普通股数 | 97.2 | 101.4 | (4)% | 98.4 | (1)% | |||||||||||||||
| 限制性股票单位 | 2.5 | 2.6 | (4)% | 2.6 | (4)% | |||||||||||||||
| 普通股份基本总股份流通 | 99.7 | 104.0 | (4)% | 101.0 | (1)% | |||||||||||||||
| 总潜在稀释股数 | 1.9 | 2.2 | (14)% | 1.8 | 6% | |||||||||||||||
| 摊薄股数总数 | 101.6 | 106.2 | (4)% | 102.8 | (1)% | |||||||||||||||
| 归还股东的资金 | ||||||||||||||||||||
| 分红派息 | $ | 150 | $ | 143 | 5% | $ | 151 | (1)% | ||||||||||||
| 普通股份回购 | 563 | 520 | 8% | 542 | 4% | |||||||||||||||
| 总资本返还给股东 | $ | 713 | $ | 663 | 8% | $ | 693 | 3% | ||||||||||||
(1) 加权股指期货是美林财富计算的股票市场走势代理，基于北美分布的股票资产，采用标准普尔500、罗素2000、罗素Midcap和MSCI EAFE指数的加权平均值计算。 | ||||||||||||||||||||
| 百分误差等于或大于100%，不具有实际意义 | ||||||||||||||||||||
10
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||||||||||||||
| 咨询与财富管理业务部门调整后营业利润率 | ||||||||||||||||||||||||||
| (以百万计，未经审计) | 2024年第3季度 | 2023年第3季度 | % 更好/ (更糟) | 2024年第2季度 | % 更好/ (更糟) | |||||||||||||||||||||
| 收入 | ||||||||||||||||||||||||||
| 管理和财务咨询费用： | ||||||||||||||||||||||||||
| 咨询费用 | $ | 1,451 | $ | 1,228 | 18% | $ | 1,361 | 7% | ||||||||||||||||||
| 财务规划费用 | 111 | 102 | 9% | 110 | 1% | |||||||||||||||||||||
| 交易和其他费用 | 97 | 94 | 3% | 100 | (3)% | |||||||||||||||||||||
| 管理和财务咨询费用总额 | 1,659 | 1,424 | 17% | 1,571 | 6% | |||||||||||||||||||||
| 分销费用： | ||||||||||||||||||||||||||
| 所有基金类型 | 209 | 184 | 14% | 199 | 5% | |||||||||||||||||||||
| 保险和年金 | 266 | 226 | 18% | 260 | 2% | |||||||||||||||||||||
| 资产负债表外的券商现金 | 32 | 58 | (45)% | 40 | (20)% | |||||||||||||||||||||
| 其他产品 | 107 | 84 | 27% | 109 | (2)% | |||||||||||||||||||||
| 总分销费用 | 614 | 552 | 11% | 608 | 1% | |||||||||||||||||||||
| 净投资收益 | 554 | 517 | 7% | 560 | (1)% | |||||||||||||||||||||
| 其他营业收入 | 78 | 65 | 20% | 77 | 1% | |||||||||||||||||||||
| 总收入 | 2,905 | 2,558 | 14% | 2,816 | 3% | |||||||||||||||||||||
| 银行和存入资金利息支出 | 163 | 151 | (8)% | 172 | 5% | |||||||||||||||||||||
| 调整后的营业总净收入 | 2,742 | 2,407 | 14% | 2,644 | 4% | |||||||||||||||||||||
| 费用 | ||||||||||||||||||||||||||
| 营销费用 | 1,488 | 1,253 | (19)% | 1,403 | (6)% | |||||||||||||||||||||
| 利息和负债费用 | 9 | 6 | (50)% | 10 | 10% | |||||||||||||||||||||
| 总务费用 | 419 | 419 | —% | 409 | (2)% | |||||||||||||||||||||
| 调整后的营业费用 | 1,916 | 1,678 | (14)% | 1,822 | (5)% | |||||||||||||||||||||
| 税前调整后营业利润 | $ | 826 | $ | 729 | 13% | $ | 822 | —% | ||||||||||||||||||
| 税前调整后的营业利润率 | 30.1 | % | 30.3 | % | 31.1 | % | ||||||||||||||||||||
11
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||||||||||||||
| 咨询与财富管理部分运营指标 | ||||||||||||||||||||||||||
| (以百万为单位，除非另有说明，未经审计) | 2024年第3季度 | 2023年第3季度 | % 更好/ (更糟) | 2024年第2季度 | % 更好/ (更糟) | |||||||||||||||||||||
| AWM总客户资产 | $ | 1,024,467 | $ | 816,019 | 26% | $ | 972,135 | 5% | ||||||||||||||||||
| 客户资金流入流出总额 | $ | 8,613 | $ | 8,901 | (3)% | $ | 6,604 | 30% | ||||||||||||||||||
| 总托管账户 | ||||||||||||||||||||||||||
| 期初资产 | $ | 534,990 | $ | 454,689 | 18% | $ | 521,722 | 3% | ||||||||||||||||||
| 净流量 | 7,992 | 5,391 | 48% | 7,521 | 6% | |||||||||||||||||||||
| 市场增值（折旧）及其他 | 26,072 | (16,019) | 未出现数据 | 5,747 | 未出现数据 | |||||||||||||||||||||
| 总和包结束资产 | $ | 569,054 | $ | 444,061 | 28% | $ | 534,990 | 6% | ||||||||||||||||||
咨询包账户资产结余 (1) | $ | 563,438 | $ | 439,341 | 28% | $ | 529,642 | 6% | ||||||||||||||||||
| 券商现金和证券余额 | ||||||||||||||||||||||||||
| 资产负债表（净投资收益） | ||||||||||||||||||||||||||
| 资产负债表 - 券商 | $ | 2,633 | $ | 2,554 | 3% | $ | 2,279 | 16% | ||||||||||||||||||
| 资产负债表 - 银行 | 21,731 | 20,970 | 4% | 21,466 | 1% | |||||||||||||||||||||
| 资产负债表-证书 | 11,998 | 12,612 | (5)% | 12,526 | (4)% | |||||||||||||||||||||
| 资产负债表合计 | $ | 36,362 | $ | 36,136 | 1% | $ | 36,271 | —% | ||||||||||||||||||
| 表外(分配费) | ||||||||||||||||||||||||||
| 表外-券商 | $ | 3,714 | $ | 4,347 | (15)% | $ | 4,359 | (15)% | ||||||||||||||||||
| 券商现金和证券总余额 | $ | 40,076 | $ | 40,483 | (1)% | $ | 40,630 | (1)% | ||||||||||||||||||
| 毛费用收益率 | ||||||||||||||||||||||||||
| 资产负债表-券商 | 5.27 | % | 5.30 | % | 5.34 | % | ||||||||||||||||||||
| 资产负债表-银行 | 5.02 | % | 4.97 | % | 5.15 | % | ||||||||||||||||||||
| 资产负债表 - 证书 | 5.63 | % | 5.40 | % | 5.66 | % | ||||||||||||||||||||
| 资产负债表之外 - 券商 | 3.28 | % | 4.28 | % | 3.08 | % | ||||||||||||||||||||
| 金融顾问 | ||||||||||||||||||||||||||
| 员工顾问 | 2,212 | 2,104 | 5% | 2,236 | (1)% | |||||||||||||||||||||
| 特许经营顾问 | 8,156 | 8,154 | —% | 8,156 | —% | |||||||||||||||||||||
| 总财务顾问 | 10,368 | 10,258 | 1% | 10,392 | —% | |||||||||||||||||||||
| 顾问保留 | ||||||||||||||||||||||||||
| 员工 | 92.5 | % | 92.2 | % | 93.2 | % | ||||||||||||||||||||
| 特许经营权 | 92.5 | % | 92.8 | % | 92.6 | % | ||||||||||||||||||||
(1) 咨询套保账户资产代表客户接受咨询服务的资产，是套保账户获得的主要营业收入来源。客户可能在其套保账户中持有非咨询投资，这些投资不会产生咨询费。 | ||||||||||||||||||||||||||
| Nm 不明确 - 方差等于或大于100% | ||||||||||||||||||||||||||
12
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||||||||||||||
| 资产管理部门调整后的营运业绩 | ||||||||||||||||||||||||||
| (以百万计，未经审计) | 2024年第3季度 | 2023年第3季度 | % 更好/ (更糟) | 2024年第2季度 | % 更好/ (更糟) | |||||||||||||||||||||
| 收入 | ||||||||||||||||||||||||||
| 管理和财务咨询费用： | ||||||||||||||||||||||||||
| 资产管理费用： | ||||||||||||||||||||||||||
| 零售 | $ | 540 | $ | 499 | 8% | $ | 522 | 3% | ||||||||||||||||||
| 机构 | 143 | 148 | (3)% | 140 | 2% | |||||||||||||||||||||
模型交付 (1) | 21 | 17 | 24% | 21 | —% | |||||||||||||||||||||
| 交易和其他费用 | 52 | 50 | 4% | 52 | —% | |||||||||||||||||||||
其他来源的营业收入 (2) | 4 | 3 | 33% | 3 | 33% | |||||||||||||||||||||
| 管理和财务咨询费用总额 | 760 | 717 | 6% | 738 | 3% | |||||||||||||||||||||
| 分销费用： | ||||||||||||||||||||||||||
| 所有基金类型 | 57 | 53 | 8% | 56 | 2% | |||||||||||||||||||||
| 保险和年金 | 41 | 39 | 5% | 40 | 3% | |||||||||||||||||||||
| 总分销费用 | 98 | 92 | 7% | 96 | 2% | |||||||||||||||||||||
| 净投资收益 | 17 | 10 | 70% | 12 | 42% | |||||||||||||||||||||
| 其他营业收入 | 7 | 7 | —% | 2 | 未出现数据 | |||||||||||||||||||||
| 总收入 | 882 | 826 | 7% | 848 | 4% | |||||||||||||||||||||
| 银行和存入资金利息支出 | — | — | —% | — | —% | |||||||||||||||||||||
| 调整后的营业总净收入 | 882 | 826 | 7% | 848 | 4% | |||||||||||||||||||||
| 费用 | ||||||||||||||||||||||||||
| 营销费用 | 250 | 234 | (7)% | 244 | (2)% | |||||||||||||||||||||
| 推迟收购成本摊销 | 2 | 1 | 未出现数据 | 1 | 未出现数据 | |||||||||||||||||||||
| 利息和负债费用 | 2 | 2 | —% | 1 | 未出现数据 | |||||||||||||||||||||
| 总务费用 | 383 | 390 | 2% | 384 | —% | |||||||||||||||||||||
| 调整后的营业费用 | 637 | 627 | (2)% | 630 | (1)% | |||||||||||||||||||||
| 税前调整后营业利润 | $ | 245 | $ | 199 | 23% | $ | 218 | 12% | ||||||||||||||||||
| 净税前调整营业利润率调解 | ||||||||||||||||||||||||||
| 调整后的营业总净收入 | $ | 882 | $ | 826 | 7% | $ | 848 | 4% | ||||||||||||||||||
| 分配通过的收入 | (198) | (186) | (6)% | (192) | (3)% | |||||||||||||||||||||
| 次级顾问和其他通过收入 | (104) | (96) | (8)% | (98) | (6)% | |||||||||||||||||||||
| 净调整营业收入 | $ | 580 | $ | 544 | 7% | $ | 558 | 4% | ||||||||||||||||||
| 税前调整后营业利润 | $ | 245 | $ | 199 | 23% | $ | 218 | 12% | ||||||||||||||||||
| 已调整的营业净投资收益 | (17) | (10) | (70)% | (12) | (42)% | |||||||||||||||||||||
| 无形资产摊销 | 9 | 5 | 80% | 4 | 未出现数据 | |||||||||||||||||||||
| 经调整的净营业收益 | $ | 237 | $ | 194 | 22% | $ | 210 | 13% | ||||||||||||||||||
| 税前调整后的营业利润率 | 27.8 | % | 24.1 | % | 25.7 | % | ||||||||||||||||||||
Net pretax adjusted operating margin (3) | 40.9 | % | 35.7 | % | 37.6 | % | ||||||||||||||||||||
总业绩费用 (4) | ||||||||||||||||||||||||||
| 业绩报酬 | $ | — | $ | 7 | 未出现数据 | $ | 2 | 未出现数据 | ||||||||||||||||||
| 与业绩费用相关的一般和行政费用 | — | 1 | 未出现数据 | 1 | 未出现数据 | |||||||||||||||||||||
| 绩效费用 | $ | — | $ | 6 | 未出现数据 | $ | 1 | 未出现数据 | ||||||||||||||||||
(1) 以符合当年报表要求的机构转为当前年度呈现的金额。 | ||||||||||||||||||||||||||
(2) 包括符合保险会计准则下的投资合同的单独账户的营业收入。 | ||||||||||||||||||||||||||
(3) 按照净调整营业收入的百分比计算，作为净调整营业利润的一部分。 | ||||||||||||||||||||||||||
(4) 绩效费用不包括CLO激励费用。 | ||||||||||||||||||||||||||
| Nm 不明确 - 方差等于或大于100% | ||||||||||||||||||||||||||
13
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||||||||||||||
| 资产管理部门运营指标 | ||||||||||||||||||||||||||
| (以百万计，未经审计) | 2024年第3季 | 2023年第3季 | % 更好/ (更糟) | 2024年第2季 | % 更好/ (更糟) | |||||||||||||||||||||
| 资产管理资产滚动 | ||||||||||||||||||||||||||
| 全球零售基金 | ||||||||||||||||||||||||||
| 起始资产 | $ | 347,460 | $ | 327,420 | 6% | $ | 349,567 | (1)% | ||||||||||||||||||
| 流入资产 | 13,129 | 11,223 | 17% | 12,536 | 5% | |||||||||||||||||||||
| 流出资产 | (15,724) | (15,166) | (4)% | (18,658) | 16% | |||||||||||||||||||||
| 净VP/VIt基金流入 | (1,741) | (1,216) | (43)% | (1,607) | (8)% | |||||||||||||||||||||
| 净新增流入 | (4,336) | (5,159) | 16% | (7,729) | 44% | |||||||||||||||||||||
| 再投资分红派息 | 1,579 | 1,320 | 20% | 1,758 | (10)% | |||||||||||||||||||||
| 净流量 | (2,757) | (3,839) | 28% | (5,971) | 54% | |||||||||||||||||||||
| 分布。在根据本收据条款的规定结束本收据所体现的协议之前，托管人将在确定余额之后以某种方式在底定时间向持有人分配或提供有关本美国存托凭证所体现的存入证券的任何现金股利、其他现金分派、股票分派、认购或其他权利或任何其他有关性质的分派，经过托管人在第十九条中描述的费用和支出的扣除或者付款，并扣除任何相关税款； ，不过需要指出，托管人不会分配可能会违反1933年证券法或任何其他适用法律的分配，并且对于任何可能违反此类法律的情况，该人不会收到相应的保证。对于这种情况，托管人可以售出这样的股份、认购或其他权利、证券或其他财产。如果托管人选择不进行任何此类分配，则托管人只需要通知持有人有关其处置的事宜及任何此类销售的收益，而任何以现金形式以外的方式通过托管人收到的任何现金股息或其他分配的，不受本第十二条的限制。托管人可以自行决定不分配任何分销或者认购权，证券或者其他财产在行使时，托管人授权此类发行人可能不得在法律上向任何持有人或者处置此类权利，以及使任何发售此类权利且在托管人处出售这类权利的净收益对这样的持有人可用。任何由托管人出售的认购权、证券或者其他财产的销售可能在托管人认为适当的时间和方式进行，并且在这种情况下，托管人应将在第十九条中描述的费用和支出扣除后分配给持有人该净收益以及在相应的代扣税或其他政府收费中将，。 | (1,770) | (1,514) | (17)% | (2,099) | 16% | |||||||||||||||||||||
| 市场升值（贬值）和其他 | 15,521 | (8,478) | 未出现数据 | 5,889 | 未出现数据 | |||||||||||||||||||||
外汇翻译(1) | 3,965 | (3,419) | 未出现数据 | 74 | 未出现数据 | |||||||||||||||||||||
| 总资产结算 | 362,419 | 310,170 | 17% | 347,460 | 4% | |||||||||||||||||||||
受托管理的零售资产总额的％ | 16.2 | % | 16.0 | % | 16.0 | % | ||||||||||||||||||||
| 全球机构 | ||||||||||||||||||||||||||
| 初始资产 | 294,420 | 289,178 | 2% | 302,510 | (3)% | |||||||||||||||||||||
流入 (2) | 8,168 | 8,404 | (3)% | 10,273 | (20)% | |||||||||||||||||||||
流出 (2) | (8,989) | (8,809) | (2)% | (16,360) | 45% | |||||||||||||||||||||
| 净流量 | (821) | (405) | 未出现数据 | (6,087) | 87% | |||||||||||||||||||||
市场升值（贬值）和其他 (3) | 7,840 | (4,607) | 未出现数据 | (2,117) | 未出现数据 | |||||||||||||||||||||
外汇翻译(1) | 8,252 | (7,165) | 未出现数据 | 114 | 未出现数据 | |||||||||||||||||||||
| 总资产结余 | 309,691 | 277,001 | 12% | 294,420 | 5% | |||||||||||||||||||||
| 总资产管理资产 | $ | 672,110 | $ | 587,171 | 14% | $ | 641,880 | 5% | ||||||||||||||||||
总管理资产净流入 | $ | (3,578) | $ | (4,244) | 16% | $ | (12,058) | 70% | ||||||||||||||||||
| 传统保险合作伙伴流入 | $ | (869) | $ | (950) | 9% | $ | (9,104) | 90% | ||||||||||||||||||
资产管理建议下的总资产 (4) | $ | 33,297 | $ | 26,756 | 24% | $ | 31,980 | 4% | ||||||||||||||||||
模型交付的总资产流入 (5) | $ | 1,212 | $ | 213 | 未出现数据 | $ | 923 | 31% | ||||||||||||||||||
总管理资产和资产管理建议下的资产流入 (5) | (2,366) | (4,031) | 41% | (11,135) | 79% | |||||||||||||||||||||
(1) 金额表示当地货币兑美元的汇率转换，用于报告目的。 | ||||||||||||||||||||||||||
(2) 全球机构的流入和流出包括来自我们RiverSource结构化年金产品和Ameriprise银行的净流入。 | ||||||||||||||||||||||||||
(3) 全球机构的市场升值（折旧）和其他方面包括关联的总账户余额变化，不包括与我们的结构化年金产品和Ameriprise银行的净流入有关的金额。 | ||||||||||||||||||||||||||
(4) 资产以一个季度的延迟呈现。 | ||||||||||||||||||||||||||
(5) AUA流量是根据资产在一个季度的变化减去基于策略回报的计算绩效而估计的流量。 | ||||||||||||||||||||||||||
| 百分误差等于或大于100%，不具有实际意义 | ||||||||||||||||||||||||||
14
| 美国健康财务（Ameriprise Financial, Inc.） | ||||||||||||||||||||||||||
| 资产管理板块运营指标 | ||||||||||||||||||||||||||
| (以百万计，未经审计) | 2024年第3季 | 2023年第3季 | % 更好/ (更糟) | 2024年第2季 | % 更好/ (更糟) | |||||||||||||||||||||
| 按类型分类的资产管理总额 | ||||||||||||||||||||||||||
| 股权 | $ | 353,812 | $ | 299,078 | 18% | $ | 340,206 | 4% | ||||||||||||||||||
| 固收 | 243,533 | 214,839 | 13% | 226,655 | 7% | |||||||||||||||||||||
| 货币市场 | 21,672 | 22,719 | (5)% | 22,759 | (5)% | |||||||||||||||||||||
| 其他 | 33,303 | 33,602 | (1)% | 33,187 | —% | |||||||||||||||||||||
| 混合和其他 | 19,790 | 16,933 | 17% | 19,073 | 4% | |||||||||||||||||||||
| 按类型划分的总管理资产 | $ | 672,110 | $ | 587,171 | 14% | $ | 641,880 | 5% | ||||||||||||||||||
按类型划分的平均管理资产 (1) | ||||||||||||||||||||||||||
| 股权 | $ | 347,466 | $ | 313,909 | 11% | $ | 336,469 | 3% | ||||||||||||||||||
| 固收 | 235,845 | 222,745 | 6% | 228,662 | 3% | |||||||||||||||||||||
| 货币市场 | 22,213 | 22,583 | (2)% | 22,540 | (1)% | |||||||||||||||||||||
| 其他 | 33,388 | 34,797 | (4)% | 33,014 | 1% | |||||||||||||||||||||
| 混合和其他 | 19,457 | 17,533 | 11% | 18,759 | 4% | |||||||||||||||||||||
| 按类型划分的总平均管理资产 | $ | 658,369 | $ | 611,567 | 8% | $ | 639,444 | 3% | ||||||||||||||||||
(1) 平均期末余额是通过上一期期末余额和当前期所有月份的平均值来计算的。 | ||||||||||||||||||||||||||
| Ameriprise Financial, Inc. | ||||||||||||||
| Asset Management Segment Performance Metrics | ||||||||||||||
| 3 Qtr 2024 | ||||||||||||||
| Retail Fund Rankings in Top 2 Quartiles or Above Index Benchmark - Asset Weighted | 1 year | 3 year | 5 year | 10 year | ||||||||||
| Equity | 40% | 69% | 78% | 86% | ||||||||||
| Fixed Income | 88% | 71% | 81% | 95% | ||||||||||
| Asset Allocation | 90% | 57% | 89% | 90% | ||||||||||
| 4- or 5-star Morningstar rated funds | Overall | 3 year | 5 year | 10 year | ||||||||||
| Number of Rated Funds | 118 | 73 | 87 | 103 | ||||||||||
| Retail Fund performance rankings for each fund are measured on a consistent basis against the most appropriate peer group or index. Peer groupings of Columbia funds are defined by Lipper category and are based on the Primary Share Class (i.e., Institutional if available, otherwise Advisor or Institutional 3 share class), net of fees. Peer groupings of Threadneedle funds are defined by either IA or Morningstar index and are based on Primary Share Class. Comparisons to Index are measured Gross of Fees. | ||||||||||||||
| To calculate asset weighted performance, the sum of the total assets of the funds with above median ranking are divided by total assets of all funds. Funds with more assets will receive a greater share of the total percentage above or below median. | ||||||||||||||
| Aggregated Asset Allocation Funds may include funds that invest in other Columbia or Threadneedle branded mutual funds included in both equity and fixed income. | ||||||||||||||
| Morningstar as of 09/30/24. Columbia funds are available for purchase by U.S. customers. Out of 89 Columbia funds rated (based on primary share class), 4 received a 5-star Overall Rating and 42 received a 4-star Overall Rating. Out of 139 Threadneedle funds rated (based on highest-rated share class), 21 received a 5-star Overall Rating and 51 received a 4-star Overall Rating. The Overall Morningstar Rating is derived from a weighted average of the performance figures associated with its 3-, 5- and 10-year (if applicable) Morningstar Rating metrics. Not all funds are available in all jurisdictions, to all investors or through all firms. © 2024 Morningstar. All rights reserved. The Morningstar information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. | ||||||||||||||
15
| Ameriprise Financial, Inc. | ||||||||||||||||||||
| Retirement & Protection Solutions Segment Adjusted Operating Results | ||||||||||||||||||||
| (in millions, unaudited) | 3 Qtr 2024 | 3 Qtr 2023 | % Better/ (Worse) | 2 Qtr 2024 | % Better/ (Worse) | |||||||||||||||
| Revenues | ||||||||||||||||||||
| Management and financial advice fees | $ | 196 | $ | 186 | 5% | $ | 189 | NM | ||||||||||||
| Distribution fees | 106 | 101 | 5% | 104 | NM | |||||||||||||||
| Net investment income | 281 | 215 | 31% | 266 | NM | |||||||||||||||
| Premiums, policy and contract charges | 388 | 372 | 4% | 367 | NM | |||||||||||||||
| Other revenues | 2 | 2 | —% | 2 | —% | |||||||||||||||
| Total revenues | 973 | 876 | 11% | 928 | NM | |||||||||||||||
| Banking and deposit interest expense | — | — | —% | — | —% | |||||||||||||||
| Adjusted operating total net revenues | 973 | 876 | 11% | 928 | NM | |||||||||||||||
| Expenses | ||||||||||||||||||||
| Distribution expenses | 131 | 117 | (12)% | 129 | (2)% | |||||||||||||||
| Interest credited to fixed accounts | 92 | 94 | 2% | 93 | 1% | |||||||||||||||
| Benefits, claims, losses and settlement expenses | 253 | 168 | (51)% | 226 | (12)% | |||||||||||||||
| Remeasurement (gains) losses of future policy benefit reserves | (25) | (10) | NM | (5) | NM | |||||||||||||||
| Change in fair value of market risk benefits | 257 | 259 | 1% | 142 | (81)% | |||||||||||||||
| Amortization of deferred acquisition costs | 57 | 57 | —% | 57 | —% | |||||||||||||||
| Interest and debt expense | 11 | 12 | 8% | 12 | 8% | |||||||||||||||
| General and administrative expense | 79 | 79 | —% | 78 | (1)% | |||||||||||||||
| Adjusted operating expenses | 855 | 776 | (10)% | 732 | (17)% | |||||||||||||||
| Pretax adjusted operating earnings | $ | 118 | $ | 100 | 18% | $ | 196 | NM | ||||||||||||
| NM Not Meaningful - variance equal to or greater than 100% | ||||||||||||||||||||
16
| Ameriprise Financial, Inc. | ||||||||||||||||||||
| Retirement & Protection Solutions Segment Operating Metrics | ||||||||||||||||||||
| (in millions, unaudited) | 3 Qtr 2024 | 3 Qtr 2023 | % Better/ (Worse) | 2 Qtr 2024 | % Better/ (Worse) | |||||||||||||||
| Variable Annuities Rollforwards | ||||||||||||||||||||
| Beginning balance | $ | 84,534 | $ | 78,549 | 8% | $ | 84,042 | 1% | ||||||||||||
| Deposits | 1,231 | 1,087 | 13% | 1,364 | (10)% | |||||||||||||||
| Withdrawals and terminations | (2,190) | (1,736) | (26)% | (2,127) | (3)% | |||||||||||||||
| Net flows | (959) | (649) | (48)% | (763) | (26)% | |||||||||||||||
| Investment performance and interest credited | 4,078 | (2,816) | NM | 1,255 | NM | |||||||||||||||
| Total ending balance - contract accumulation values | $ | 87,653 | $ | 75,084 | 17% | $ | 84,534 | 4% | ||||||||||||
| Variable annuities fixed sub-accounts | $ | 3,837 | $ | 4,395 | (13)% | $ | 3,935 | (2)% | ||||||||||||
| Life Insurance In Force | $ | 198,198 | $ | 198,527 | —% | $ | 198,340 | —% | ||||||||||||
| Net Amount at Risk (Life) | $ | 37,895 | $ | 37,917 | —% | $ | 38,203 | (1)% | ||||||||||||
| Net Policyholder Reserves | ||||||||||||||||||||
| VUL/UL | $ | 15,984 | $ | 13,814 | 16% | $ | 15,475 | 3% | ||||||||||||
| Term and whole life | 182 | 175 | 4% | 174 | 5% | |||||||||||||||
| Disability insurance | 503 | 500 | 1% | 505 | —% | |||||||||||||||
| Other insurance | 513 | 542 | (5)% | 524 | (2)% | |||||||||||||||
| Total net policyholder reserves | $ | 17,182 | $ | 15,031 | 14% | $ | 16,678 | 3% | ||||||||||||
| DAC Ending Balances | ||||||||||||||||||||
| Variable Annuities DAC | $ | 1,684 | $ | 1,713 | (2)% | $ | 1,692 | —% | ||||||||||||
| Life and Health DAC | $ | 955 | $ | 963 | (1)% | $ | 956 | —% | ||||||||||||
| NM Not Meaningful - variance equal to or greater than 100% | ||||||||||||||||||||
17
| Ameriprise Financial, Inc. | ||||||||||||||||||||
| Corporate Segment Adjusted Operating Results and Metrics | ||||||||||||||||||||
| (in millions, unaudited) | 3 Qtr 2024 | 3 Qtr 2023 | % Better/ (Worse) | 2 Qtr 2024 | % Better/ (Worse) | |||||||||||||||
| Corporate Excluding Long Term Care and Fixed Annuities Adjusted Operating Income Statements | ||||||||||||||||||||
| Revenues | ||||||||||||||||||||
| Management and financial advice fees | $ | — | $ | — | —% | $ | — | —% | ||||||||||||
| Distribution fees | — | — | —% | — | —% | |||||||||||||||
| Net investment income | (4) | 17 | NM | (9) | 56% | |||||||||||||||
| Premiums, policy and contract charges | — | — | —% | — | —% | |||||||||||||||
| Other revenues | 1 | 2 | (50)% | 3 | (67)% | |||||||||||||||
| Total revenues | (3) | 19 | NM | (6) | 50% | |||||||||||||||
| Banking and deposit interest expense | 7 | 6 | (17)% | 7 | —% | |||||||||||||||
| Adjusted operating total net revenues | (10) | 13 | NM | (13) | 23% | |||||||||||||||
| Expenses | ||||||||||||||||||||
| Distribution expenses | — | — | —% | — | —% | |||||||||||||||
| Interest credited to fixed accounts | — | — | —% | — | —% | |||||||||||||||
| Benefits, claims, losses and settlement expenses | — | — | —% | — | —% | |||||||||||||||
| Remeasurement (gains) losses of future policy benefit reserves | — | — | —% | — | —% | |||||||||||||||
| Change in fair value of market risk benefits | — | — | —% | — | —% | |||||||||||||||
| Amortization of deferred acquisition costs | — | — | —% | — | —% | |||||||||||||||
| Interest and debt expense | 30 | 27 | (11)% | 24 | (25)% | |||||||||||||||
| General and administrative expense | 105 | 60 | (75)% | 86 | (22)% | |||||||||||||||
| Adjusted operating expenses | 135 | 87 | (55)% | 110 | (23)% | |||||||||||||||
| Pretax adjusted operating earnings (loss) | $ | (145) | $ | (74) | (96)% | $ | (123) | (18)% | ||||||||||||
| NM Not Meaningful - variance equal to or greater than 100% | ||||||||||||||||||||
18
| Ameriprise Financial, Inc. | ||||||||||||||||||||
| Corporate Segment Adjusted Operating Results and Metrics | ||||||||||||||||||||
| (in millions, unaudited) | 3 Qtr 2024 | 3 Qtr 2023 | % Better/ (Worse) | 2 Qtr 2024 | % Better/ (Worse) | |||||||||||||||
| Long Term Care Adjusted Operating Income Statements | ||||||||||||||||||||
| Revenues | ||||||||||||||||||||
| Management and financial advice fees | $ | — | $ | — | —% | $ | — | —% | ||||||||||||
| Distribution fees | — | — | —% | — | —% | |||||||||||||||
| Net investment income | 49 | 46 | 7% | 48 | 2% | |||||||||||||||
| Premiums, policy and contract charges | 24 | 25 | (4)% | 22 | 9% | |||||||||||||||
| Other revenues | — | — | —% | — | —% | |||||||||||||||
| Total revenues | 73 | 71 | 3% | 70 | 4% | |||||||||||||||
| Banking and deposit interest expense | 1 | — | —% | — | —% | |||||||||||||||
| Adjusted operating total net revenues | 72 | 71 | 1% | 70 | 3% | |||||||||||||||
| Expenses | ||||||||||||||||||||
| Distribution expenses | (4) | (3) | 33% | (2) | NM | |||||||||||||||
| Interest credited to fixed accounts | — | — | —% | — | —% | |||||||||||||||
| Benefits, claims, losses and settlement expenses | 56 | 58 | 3% | 56 | —% | |||||||||||||||
| Remeasurement (gains) losses of future policy benefit reserves | 3 | (2) | NM | (3) | NM | |||||||||||||||
| Change in fair value of market risk benefits | — | — | —% | — | —% | |||||||||||||||
| Amortization of deferred acquisition costs | — | — | —% | — | —% | |||||||||||||||
| Interest and debt expense | 2 | 1 | NM | 1 | NM | |||||||||||||||
| General and administrative expense | 6 | 7 | 14% | 6 | —% | |||||||||||||||
| Adjusted operating expenses | 63 | 61 | (3)% | 58 | (9)% | |||||||||||||||
| Pretax adjusted operating earnings (loss) | $ | 9 | $ | 10 | (10)% | $ | 12 | (25)% | ||||||||||||
| Long Term Care Policyholder Reserves, net of reinsurance | $ | 2,702 | $ | 2,456 | 10% | $ | 2,557 | 6% | ||||||||||||
| NM Not Meaningful - variance equal to or greater than 100% | ||||||||||||||||||||
19
| Ameriprise Financial, Inc. | ||||||||||||||||||||||||||
| Corporate Segment Adjusted Operating Results and Metrics | ||||||||||||||||||||||||||
| (in millions, unaudited) | 3 Qtr 2024 | 3 Qtr 2023 | % Better/ (Worse) | 2 Qtr 2024 | % Better/ (Worse) | |||||||||||||||||||||
| Fixed Annuities Adjusted Operating Income Statements | ||||||||||||||||||||||||||
| Revenues | ||||||||||||||||||||||||||
| Management and financial advice fees | $ | — | $ | — | —% | $ | — | —% | ||||||||||||||||||
| Distribution fees | — | 1 | NM | — | —% | |||||||||||||||||||||
| Net investment income | 8 | 8 | —% | 8 | —% | |||||||||||||||||||||
| Premiums, policy and contract charges | — | — | —% | 1 | NM | |||||||||||||||||||||
| Other revenues | 44 | 50 | (12)% | 45 | (2)% | |||||||||||||||||||||
| Total revenues | 52 | 59 | (12)% | 54 | (4)% | |||||||||||||||||||||
| Banking and deposit interest expense | (1) | — | —% | — | —% | |||||||||||||||||||||
| Adjusted operating total net revenues | 53 | 59 | (10)% | 54 | (2)% | |||||||||||||||||||||
| Expenses | ||||||||||||||||||||||||||
| Distribution expenses | 1 | — | —% | — | —% | |||||||||||||||||||||
| Interest credited to fixed accounts | 55 | 59 | 7% | 54 | (2)% | |||||||||||||||||||||
| Benefits, claims, losses and settlement expenses | — | 1 | NM | 1 | NM | |||||||||||||||||||||
| Remeasurement (gains) losses of future policy benefit reserves | — | — | —% | — | —% | |||||||||||||||||||||
| Change in fair value of market risk benefits | — | — | —% | — | —% | |||||||||||||||||||||
| Amortization of deferred acquisition costs | — | 4 | NM | 3 | NM | |||||||||||||||||||||
| Interest and debt expense | — | — | —% | 1 | NM | |||||||||||||||||||||
| General and administrative expense | 4 | 3 | (33)% | 3 | (33)% | |||||||||||||||||||||
| Adjusted operating expenses | 60 | 67 | 10% | 62 | 3% | |||||||||||||||||||||
| Pretax adjusted operating earnings (loss) | $ | (7) | $ | (8) | 13% | $ | (8) | 13% | ||||||||||||||||||
| NM Not Meaningful - variance equal to or greater than 100% | ||||||||||||||||||||||||||
20
| Ameriprise Financial, Inc. | ||||||||||||||||||||
Eliminations (1) Adjusted Operating Results | ||||||||||||||||||||
| (in millions, unaudited) | 3 Qtr 2024 | 3 Qtr 2023 | % Better/ (Worse) | 2 Qtr 2024 | % Better/ (Worse) | |||||||||||||||
| Revenues | ||||||||||||||||||||
| Management and financial advice fees | $ | (40) | $ | (38) | (5)% | $ | (41) | 2% | ||||||||||||
| Distribution fees | (305) | (283) | (8)% | (303) | (1)% | |||||||||||||||
| Net investment income | (21) | (14) | (50)% | (15) | (40)% | |||||||||||||||
| Premiums, policy and contract charges | (9) | (8) | (13)% | (8) | (13)% | |||||||||||||||
| Other revenues | 1 | — | —% | — | —% | |||||||||||||||
| Total revenues | (374) | (343) | (9)% | (367) | (2)% | |||||||||||||||
| Banking and deposit interest expense | (7) | (6) | 17% | (7) | —% | |||||||||||||||
| Adjusted operating total net revenues | (367) | (337) | (9)% | (360) | (2)% | |||||||||||||||
| Expenses | ||||||||||||||||||||
| Distribution expenses | (327) | (304) | 8% | (324) | 1% | |||||||||||||||
| Interest credited to fixed accounts | — | — | —% | — | —% | |||||||||||||||
| Benefits, claims, losses and settlement expenses | (5) | (4) | 25% | (5) | —% | |||||||||||||||
| Remeasurement (gains) losses of future policy benefit reserves | — | — | —% | — | —% | |||||||||||||||
| Change in fair value of market risk benefits | — | — | —% | — | —% | |||||||||||||||
| Amortization of deferred acquisition costs | — | — | —% | — | —% | |||||||||||||||
| Interest and debt expense | (14) | (9) | 56% | (9) | 56% | |||||||||||||||
| General and administrative expense | (21) | (20) | 5% | (22) | (5)% | |||||||||||||||
| Adjusted operating expenses | (367) | (337) | 9% | (360) | 2% | |||||||||||||||
| Pretax adjusted operating earnings (loss) | $ | — | $ | — | —% | $ | — | —% | ||||||||||||
(1) The majority of the amounts represent the impact of inter-segment transfer pricing for both revenues and expenses. | ||||||||||||||||||||
21
| Ameriprise Financial, Inc. | ||||||||||||||||||||
| Capital Information | ||||||||||||||||||||
| (in millions, unaudited) | September 30, 2024 | September 30, 2023 | June 30, 2024 | |||||||||||||||||
| Long-term Debt Summary | ||||||||||||||||||||
| Senior notes | $ | 3,400 | $ | 3,550 | $ | 3,400 | ||||||||||||||
| Finance lease liabilities | 11 | 22 | 15 | |||||||||||||||||
Other (1) | (17) | (15) | (19) | |||||||||||||||||
| Total Ameriprise Financial long-term debt | 3,394 | 3,557 | 3,396 | |||||||||||||||||
| Non-recourse debt of consolidated investment entities | 2,271 | 2,222 | 2,386 | |||||||||||||||||
| Total long-term debt | $ | 5,665 | $ | 5,779 | $ | 5,782 | ||||||||||||||
| Total Ameriprise Financial long-term debt | $ | 3,394 | $ | 3,557 | $ | 3,396 | ||||||||||||||
| Finance lease liabilities | (11) | (22) | (15) | |||||||||||||||||
Other (1) | 17 | 15 | 19 | |||||||||||||||||
| Total Ameriprise Financial long-term debt excluding finance lease liabilities and other | $ | 3,400 | $ | 3,550 | $ | 3,400 | ||||||||||||||
Total equity (2) | $ | 5,715 | $ | 3,825 | $ | 4,993 | ||||||||||||||
| Equity of consolidated investment entities | (1) | (10) | (1) | |||||||||||||||||
| Total equity excluding CIEs | $ | 5,714 | $ | 3,815 | $ | 4,992 | ||||||||||||||
| Total Ameriprise Financial capital | $ | 9,109 | $ | 7,382 | $ | 8,389 | ||||||||||||||
| Total Ameriprise Financial capital excluding finance lease liabilities, other and equity of CIEs | $ | 9,114 | $ | 7,365 | $ | 8,392 | ||||||||||||||
| Debt to capital | ||||||||||||||||||||
| Total Ameriprise Financial long-term debt to total Ameriprise Financial capital | 37.3 | % | 48.2 | % | 40.5 | % | ||||||||||||||
Total Ameriprise Financial long-term debt to total Ameriprise Financial capital excluding finance lease liabilities, other and equity of CIEs (2) | 37.3 | % | 48.2 | % | 40.5 | % | ||||||||||||||
| Available Capital for Capital Adequacy | $ | 5,523 | $ | 5,247 | $ | 5,245 | ||||||||||||||
(1) Includes adjustments for net unamortized discounts, debt issuance costs and other lease obligations. | ||||||||||||||||||||
(2) Includes accumulated other comprehensive income, net of tax. | ||||||||||||||||||||
22
| Ameriprise Financial, Inc. | ||||||||||||||
| Consolidated Balance Sheets | ||||||||||||||
| (in millions, unaudited) | September 30, 2024 | December 31, 2023 | ||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 10,575 | $ | 7,477 | ||||||||||
| Cash of consolidated investment entities | 124 | 87 | ||||||||||||
| Investments | 56,703 | 55,489 | ||||||||||||
| Investments of consolidated investment entities | 2,243 | 2,099 | ||||||||||||
| Market risk benefits | 1,809 | 1,427 | ||||||||||||
| Separate account assets | 81,409 | 77,457 | ||||||||||||
| Receivables | 14,768 | 15,078 | ||||||||||||
| Receivables of consolidated investment entities | 18 | 28 | ||||||||||||
| Deferred acquisition costs | 2,686 | 2,713 | ||||||||||||
| Restricted and segregated cash and investments | 1,261 | 1,635 | ||||||||||||
| Other assets | 14,372 | 11,700 | ||||||||||||
| Other assets of consolidated investment entities | 1 | 1 | ||||||||||||
| Total Assets | $ | 185,969 | $ | 175,191 | ||||||||||
| Liabilities | ||||||||||||||
| Policyholder account balances, future policy benefits and claims | $ | 41,332 | $ | 37,545 | ||||||||||
| Market risk benefits | 1,579 | 1,762 | ||||||||||||
| Separate account liabilities | 81,409 | 77,457 | ||||||||||||
| Customer deposits | 36,332 | 37,321 | ||||||||||||
| Short-term borrowings | 201 | 201 | ||||||||||||
| Long-term debt | 3,394 | 3,399 | ||||||||||||
| Debt of consolidated investment entities | 2,271 | 2,155 | ||||||||||||
| Accounts payable and accrued expenses | 2,581 | 2,603 | ||||||||||||
| Other liabilities | 11,072 | 7,974 | ||||||||||||
| Other liabilities of consolidated investment entities | 83 | 45 | ||||||||||||
| Total Liabilities | 180,254 | 170,462 | ||||||||||||
| Equity | ||||||||||||||
| Ameriprise Financial | ||||||||||||||
| Common shares ($.01 par) | 3 | 3 | ||||||||||||
| Additional paid-in capital | 10,050 | 9,824 | ||||||||||||
| Retained earnings | 23,791 | 21,905 | ||||||||||||
| Treasury stock | (27,028) | (25,237) | ||||||||||||
| Accumulated other comprehensive income, net of tax | (1,101) | (1,766) | ||||||||||||
| Total Equity | 5,715 | 4,729 | ||||||||||||
| Total Liabilities and Equity | $ | 185,969 | $ | 175,191 | ||||||||||
| Supplemental Non-GAAP Information: | ||||||||||||||
| Available Capital for Capital Adequacy | $ | 5,523 | $ | 5,418 | ||||||||||
23
| Ameriprise Financial, Inc. | |||||||||||||||||||||||||||||||||||
| Reconciliation Table: Earnings | |||||||||||||||||||||||||||||||||||
| Quarter Ended September 30, | % Better/ (Worse) | Per Diluted Share Quarter Ended September 30, | % Better/ (Worse) | ||||||||||||||||||||||||||||||||
| (in millions, except per share amounts, unaudited) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||||||||||
| Net income | $ | 511 | $ | 872 | (41)% | $ | 5.00 | $ | 8.14 | (39)% | |||||||||||||||||||||||||
| Adjustments: | |||||||||||||||||||||||||||||||||||
Net realized investment gains (losses) (1) | (6) | (38) | (0.06) | (0.35) | |||||||||||||||||||||||||||||||
Market impact on non-traditional long-duration products (1) | (402) | 211 | (3.93) | 1.96 | |||||||||||||||||||||||||||||||
Mean reversion-related impacts (1) | 1 | — | 0.01 | — | |||||||||||||||||||||||||||||||
Integration/restructuring charges (1) | — | (12) | — | (0.11) | |||||||||||||||||||||||||||||||
| Net income (loss) attributable to consolidated investment entities | 5 | — | 0.05 | — | |||||||||||||||||||||||||||||||
Tax effect of adjustments (2) | 85 | (34) | 0.83 | (0.32) | |||||||||||||||||||||||||||||||
| Adjusted operating earnings | $ | 828 | $ | 745 | 11% | $ | 8.10 | $ | 6.96 | 16% | |||||||||||||||||||||||||
| Pretax impact of annual unlocking | (94) | (99) | (0.92) | (0.92) | |||||||||||||||||||||||||||||||
Tax effect of annual unlocking (2) | 20 | 21 | 0.19 | 0.20 | |||||||||||||||||||||||||||||||
| Adjusted operating earnings excluding unlocking | $ | 902 | $ | 823 | 10% | $ | 8.83 | $ | 7.68 | 15% | |||||||||||||||||||||||||
| Pretax impact of severance expense | (24) | (7) | (0.24) | (0.07) | |||||||||||||||||||||||||||||||
| Tax effect of severance expense | 5 | 1 | 0.05 | 0.01 | |||||||||||||||||||||||||||||||
| Adjusted operating earnings excluding unlocking and severance expense | $ | 921 | $ | 829 | 11% | $ | 9.02 | $ | 7.74 | 17% | |||||||||||||||||||||||||
| Weighted average common shares outstanding: | |||||||||||||||||||||||||||||||||||
| Basic | 100.4 | 104.9 | |||||||||||||||||||||||||||||||||
| Diluted | 102.2 | 107.1 | |||||||||||||||||||||||||||||||||
(1) Pretax adjusted operating adjustment. | |||||||||||||||||||||||||||||||||||
(2) Calculated using the statutory tax rate of 21%. | |||||||||||||||||||||||||||||||||||
24
| Ameriprise Financial, Inc. | |||||||||||||||||||||||||||||||||||
| Reconciliation Table: Earnings | |||||||||||||||||||||||||||||||||||
| Year-to-date September 30, | % Better/ (Worse) | Per Diluted Share Year-to-date September 30, | % Better/ (Worse) | ||||||||||||||||||||||||||||||||
| (in millions, except per share amounts, unaudited) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||||||||||
| Net income | $ | 2,330 | $ | 2,179 | 7% | $ | 22.53 | $ | 20.08 | 12% | |||||||||||||||||||||||||
| Adjustments: | |||||||||||||||||||||||||||||||||||
Net realized investment gains (losses) (1) | (9) | (32) | (0.09) | (0.29) | |||||||||||||||||||||||||||||||
Market impact on non-traditional long-duration products (1) | (322) | (137) | (3.11) | (1.27) | |||||||||||||||||||||||||||||||
Mean reversion-related impacts (1) | 1 | — | 0.01 | — | |||||||||||||||||||||||||||||||
Integration/restructuring charges (1) | — | (47) | — | (0.43) | |||||||||||||||||||||||||||||||
| Net income (loss) attributable to consolidated investment entities | 3 | — | 0.03 | — | |||||||||||||||||||||||||||||||
Tax effect of adjustments (2) | 69 | 45 | 0.66 | 0.41 | |||||||||||||||||||||||||||||||
| Adjusted operating earnings | $ | 2,588 | $ | 2,350 | 10% | $ | 25.03 | $ | 21.66 | 16% | |||||||||||||||||||||||||
| Pretax impact of annual unlocking | (94) | (99) | (0.91) | (0.91) | |||||||||||||||||||||||||||||||
Tax effect of annual unlocking (2) | 20 | 21 | 0.20 | 0.19 | |||||||||||||||||||||||||||||||
| Adjusted operating earnings excluding unlocking | $ | 2,662 | $ | 2,428 | 10% | $ | 25.74 | $ | 22.38 | 15% | |||||||||||||||||||||||||
| Pretax impact of severance expense | (54) | (7) | (0.52) | (0.06) | |||||||||||||||||||||||||||||||
Tax effect of severance expense (2) | 11 | 1 | 0.11 | 0.01 | |||||||||||||||||||||||||||||||
| Adjusted operating earnings excluding unlocking and severance expense | $ | 2,705 | $ | 2,434 | 11% | $ | 26.15 | $ | 22.43 | 17% | |||||||||||||||||||||||||
| Weighted average common shares outstanding: | |||||||||||||||||||||||||||||||||||
| Basic | 101.6 | 106.4 | |||||||||||||||||||||||||||||||||
| Diluted | 103.4 | 108.5 | |||||||||||||||||||||||||||||||||
(1) Pretax adjusted operating adjustment. | |||||||||||||||||||||||||||||||||||
(2) Calculated using the statutory tax rate of 21%. | |||||||||||||||||||||||||||||||||||
25
| Ameriprise Financial, Inc. | ||||||||||||||
Reconciliation Table: Pretax Adjusted Operating Earnings | ||||||||||||||
| Quarter Ended September 30, | ||||||||||||||
| (in millions, unaudited) | 2024 | 2023 | ||||||||||||
| Total net revenues | $ | 4,397 | $ | 3,925 | ||||||||||
| Adjustments: | ||||||||||||||
| Net realized investment gains (losses) | (6) | (38) | ||||||||||||
| Market impact on non-traditional long-duration products | 5 | 3 | ||||||||||||
| CIEs revenue | 53 | 45 | ||||||||||||
| Adjusted operating total net revenues | $ | 4,345 | $ | 3,915 | ||||||||||
| Annual unlocking | (5) | 1 | ||||||||||||
| Adjusted operating total net revenues excluding unlocking | $ | 4,350 | $ | 3,914 | ||||||||||
| Total expenses | $ | 3,752 | $ | 2,808 | ||||||||||
| Adjustments: | ||||||||||||||
| CIEs expenses | 47 | 45 | ||||||||||||
| Integration/restructuring charges | — | 12 | ||||||||||||
| Market impact on non-traditional long-duration products | 407 | (208) | ||||||||||||
| Mean reversion-related impacts | (1) | — | ||||||||||||
| Adjusted operating expenses | $ | 3,299 | $ | 2,959 | ||||||||||
| Annual unlocking | 89 | 100 | ||||||||||||
| Adjusted operating total net expenses excluding unlocking | $ | 3,210 | $ | 2,859 | ||||||||||
| Severance expense | 24 | 7 | ||||||||||||
| Adjusted operating total net expenses excluding unlocking and severance expense | $ | 3,186 | $ | 2,852 | ||||||||||
| Pretax income | $ | 645 | $ | 1,117 | ||||||||||
| Pretax adjusted operating earnings | $ | 1,046 | $ | 956 | ||||||||||
| Pretax adjusted operating earnings excluding unlocking and severance expense | $ | 1,164 | $ | 1,062 | ||||||||||
| Pretax income margin | 14.7 | % | 28.5 | % | ||||||||||
| Pretax adjusted operating margin | 24.1 | % | 24.4 | % | ||||||||||
| Pretax adjusted operating margin excluding unlocking and severance expense | 26.8 | % | 27.1 | % | ||||||||||
26
| Ameriprise Financial, Inc. | ||||||||||||||||||||
| Reconciliation Table: Available Capital for Capital Adequacy | ||||||||||||||||||||
| (in millions, unaudited) | September 30, 2024 | September 30, 2023 | June 30, 2024 | |||||||||||||||||
| Ameriprise Financial GAAP Equity | $ | 5,715 | $ | 3,825 | $ | 4,993 | ||||||||||||||
| Less: AOCI | (1,101) | (2,840) | (1,993) | |||||||||||||||||
| Ameriprise Financial GAAP Equity, excl AOCI | 6,816 | 6,665 | 6,986 | |||||||||||||||||
| Less: RiverSource Life Insurance Co. GAAP Equity, excluding AOCI | 1,658 | 2,084 | 2,012 | |||||||||||||||||
| Add: RiverSource Life Insurance Co. statutory total adjusted capital | 2,721 | 2,842 | 2,598 | |||||||||||||||||
| Less: Goodwill and intangibles | 2,626 | 2,487 | 2,595 | |||||||||||||||||
| Add: Other adjustments | 270 | 311 | 268 | |||||||||||||||||
| Available Capital for Capital Adequacy | $ | 5,523 | $ | 5,247 | $ | 5,245 | ||||||||||||||
| Ameriprise Financial, Inc. | ||||||||||||||
| Reconciliation Table: Effective Tax Rate | ||||||||||||||
| Quarter Ended September 30, 2023 | ||||||||||||||
| (in millions, unaudited) | GAAP | Adjusted Operating | ||||||||||||
| Pretax income | $ | 1,117 | $ | 956 | ||||||||||
| Income tax provision | $ | 245 | $ | 211 | ||||||||||
| Effective tax rate | 21.8 | % | 22.1 | % | ||||||||||
| Ameriprise Financial, Inc. | ||||||||||||||
| Reconciliation Table: Effective Tax Rate | ||||||||||||||
| Quarter Ended September 30, 2024 | ||||||||||||||
| (in millions, unaudited) | GAAP | Adjusted Operating | ||||||||||||
| Pretax income | $ | 645 | $ | 1,046 | ||||||||||
| Income tax provision | $ | 134 | $ | 218 | ||||||||||
| Effective tax rate | 20.7 | % | 20.8 | % | ||||||||||
27
| Ameriprise Financial, Inc. | ||||||||||||||
| Reconciliation Table: Effective Tax Rate | ||||||||||||||
| Year-to-date September 30, 2024 | ||||||||||||||
| (in millions, unaudited) | GAAP | Adjusted Operating | ||||||||||||
| Pretax income | $ | 2,915 | $ | 3,241 | ||||||||||
| Income tax provision | $ | 585 | $ | 653 | ||||||||||
| Effective tax rate | 20.0 | % | 20.1 | % | ||||||||||
| Ameriprise Financial, Inc. | |||||||||||||||||
Reconciliation Table: Advice & Wealth Management General and Administrative Expense | |||||||||||||||||
| Quarter Ended September 30, | % Better/ (Worse) | ||||||||||||||||
| (in millions, unaudited) | 2024 | 2023 | |||||||||||||||
| AWM general and administrative expense | $ | 419 | $ | 419 | —% | ||||||||||||
| Less: Regulatory accrual | — | 20 | |||||||||||||||
| AWM general and administrative expense excluding accrual for regulatory matter | $ | 419 | $ | 399 | (5)% | ||||||||||||
28
| Ameriprise Financial, Inc. | |||||||||||||||||
| Reconciliation Table: Return on Equity (ROE) Excluding Accumulated Other Comprehensive Income “AOCI” | |||||||||||||||||
| Twelve Months Ended September 30, | |||||||||||||||||
| (in millions, unaudited) | 2024 | 2023 | |||||||||||||||
| Net income | $ | 2,707 | $ | 2,828 | |||||||||||||
Less: Adjustments (1) | (642) | (254) | |||||||||||||||
| Adjusted operating earnings | 3,349 | 3,082 | |||||||||||||||
Less: Annual unlocking (2) | (74) | (78) | |||||||||||||||
Adjusted operating earnings excluding unlocking | $ | 3,423 | $ | 3,160 | |||||||||||||
| Total Ameriprise Financial, Inc. shareholders’ equity | $ | 4,828 | $ | 3,894 | |||||||||||||
| Less: Accumulated other comprehensive income, net of tax | (1,926) | (2,477) | |||||||||||||||
| Total Ameriprise Financial, Inc. shareholders’ equity excluding AOCI | 6,754 | 6,371 | |||||||||||||||
| Less: Equity impacts attributable to the consolidated investment entities | (3) | (3) | |||||||||||||||
| Adjusted operating equity | $ | 6,757 | $ | 6,374 | |||||||||||||
| Return on equity excluding AOCI | 40.1 | % | 44.4 | % | |||||||||||||
Adjusted operating return on equity excluding AOCI (3) | 49.6 | % | 48.4 | % | |||||||||||||
Adjusted operating return on equity excluding AOCI and unlocking (3) | 50.7 | % | 49.6 | % | |||||||||||||
(1) Adjustments reflect the sum of after-tax net realized investment gains/losses, net of the reinsurance accrual; the market impact on non-traditional long-duration products (including variable and fixed deferred annuity contracts and UL insurance contracts), net of hedges and related reinsurance accrual; mean reversion related impacts; block transfer reinsurance transaction impacts; the market impact of hedges to offset interest rate and currency changes on unrealized gains or losses for certain investments; gain or loss on disposal of a business that is not considered discontinued operations; integration and restructuring charges; income (loss) from discontinued operations; and net income (loss) from consolidated investment entities. After-tax is calculated using the statutory tax rate of 21%. | |||||||||||||||||
(2) After-tax is calculated using the statutory tax rate of 21%. | |||||||||||||||||
(3) Adjusted operating return on equity, excluding AOCI is calculated using adjusted operating earnings in the numerator, and Ameriprise Financial shareholders’ equity, excluding AOCI and the impact of consolidating investment entities using a five-point average of quarter-end equity in the denominator. After-tax is calculated using the statutory tax rate of 21%. | |||||||||||||||||
29